HER2-Low expression in primary male breast cancer

被引：0
|
作者：
Rudlowski, Christian [1 ]
Erices-Leclercq, Melanie [1 ]
Nobbe, Katleen [1 ]
Baldus, Stephan [2 ]
Foerster, Robert [3 ]
Foerster, Frank [4 ]
Lubig, Sabine [1 ]
机构：
[1] EVK, Bergisch Gladbach, Germany
[2] Inst Pathol & Zytopathol, Bergisch Gladbach, Germany
[3] Cantonal Hosp Winterthur, Inst Radiat Oncol, Winterthur, Switzerland
[4] Poliklinik GmbH, MVZ Gynakol Onkol & Palliat Med, Chemnitz, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
96
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [31] Computational pathology based HER2 expression quantification in HER2-low breast cancer
    Spitzmueller, Andreas
    Kapil, Ansh
    Shumilov, Anatoliy
    Chan, Jessica
    Konstantinidou, Lemonia
    Hassan, Zonera
    Gustavson, Mark
    Carroll, Danielle
    Della Varghese
    James, Gareth D.
    Moh, Akira
    Livingston, Andrew
    de Giorgio-Miller, Victoria
    CANCER RESEARCH, 2023, 83 (05)
  • [32] A comparison between immunohistochemistry and mRNA expression to detect HER2-low breast cancer
    Navarro, X. Baez
    van Bockstal, M. R.
    van der Made, A.
    van Deurzen, C. H. M.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 104 - 104
  • [33] Clinical and Epidemiologic Significance of HER2-Low Expression in Breast Cancer in the Pathways Study
    Khoury, Thaer
    Ondracek, Rochelle Payne
    Yao, Song
    Mendocino, Lucas
    Davis, Warren
    Omilian, Angela
    Kwan, Marilyn
    Roh, Janise
    D'Addario, Lia
    Valice, Emily
    Fernandez, Daniel
    Ergas, Isaac
    Ambrosone, Christine
    Kushi, Lawrence
    CANCER RESEARCH, 2024, 84 (09)
  • [34] Association between HER2-low expression and prognostic clinicopathologic factors in breast cancer
    Akkurt, T. Soylemez
    Gurbuz, B. Calim
    Sen, E.
    HISTOPATHOLOGY, 2022, 81 : 22 - 22
  • [35] Genomic and Transcriptomic Landscape of HER2-Low Breast Cancer
    Bansal, Rani
    McGrath, Julie
    Walker, Phil
    Bustos, Matias A.
    Rodriguez, Estelamari
    Sammons, Sarah L.
    Accordino, Melissa K.
    Meisel, Jane
    Gatti-Mays, Margaret
    Hsu, Emily
    Lathrop, Kate I.
    Kaklamani, Virginia
    Oberley, Matthew
    Korn, W. Michael
    Graff, Stephanie L.
    CANCER RESEARCH, 2023, 83 (05)
  • [36] Comprehensive genomic characterization of HER2-low breast cancer
    Tarantino, Paolo
    Gupta, Hersh V.
    Hughes, Melissa E.
    Files, Janet L.
    Strauss, Sarah
    Kirkner, Gregory
    Feeney, Anne-Marie
    Li, Yvonne Y.
    Garrido-Castro, Ana C.
    Barroso-Sousa, Romualdo
    Bychkovsky, Brittany
    MacConaill, Laura
    Lindeman, Neal
    Johnson, Bruce
    Meyerson, Matthew
    Kabraji, Sheheryar
    Jeselsohn, Rinath
    Qiu, Xintao
    Li, Rong
    Long, Henry W.
    Winer, Eric
    Dillon, Deborah A.
    Curigliano, Giuseppe
    Cherniack, Andrew
    Tolaney, Sara
    Lin, Nancy U.
    CANCER RESEARCH, 2023, 83 (05)
  • [37] Frequency of HER2-Low in breast cancer biopsies in Chile
    Vidal, Martin
    Rivera, Alvaro
    Schuler, Constanza
    Garnham, Nicolas
    Alcalde, Elisa
    Renner, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] TRASTUZUMAB DERUXTECAN IS EFFECTIVE IN HER2-LOW BREAST CANCER
    不详
    CANCER DISCOVERY, 2020, 10 (04) : 488 - 488
  • [39] HER2-low breast cancer: insights on pathological testing
    Liu, Yueping
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [40] HER2-Low Breast Cancer: Pathological and Clinical Landscape
    Tarantino, Paolo
    Hamilton, Erika
    Tolaney, Sara M.
    Cortes, Javier
    Morganti, Stefania
    Ferraro, Emanuela
    Marra, Antonio
    Viale, Giulia
    Trapani, Dario
    Cardoso, Fatima
    Penault-Llorca, Frederique
    Viale, Giuseppe
    Andre, Fabrice
    Curigliano, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (17) : 1951 - +
12345